International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma
By K. Chung, Sally E. Wenzel, J. Brożek, A. Bush, M. Castro, P. Sterk, Ian M. Adcock, E. Bateman, E. Bel, E. Bleecker and 13 more. European Respiratory Journal, 2013
3,557 citations recorded by the source corpus.
Subfields: Physiology, Pulmonary and Respiratory Medicine
View Paper: https://www.semanticscholar.org/paper/1b0184ae22ca3db87d11c8e7c954b54dc99886a4
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Physiology
In Pulmonary and Respiratory Medicine
Citations in the corpus
- A summary of the new GINA strategy: a roadmap to asthma control (2015, methodology): “The recommendations about assessment of severe asthma follow the 2014 ERS/ATS task force guidelines [33], with the caution that the task force lung function criterion (a pre-bronchodilator FEV 1 of 80% predicted in the previous year) may lead to over-classification of asthma as severe.”
- Mepolizumab treatment in patients with severe eosinophilic asthma. (2014, neutral): “Oropharyngeal pain 15 (8) 12 (6) 7 (4)”
- Global Initiative for Asthma Strategy 2021: Executive Summary and Rationale for Key Changes (2021, neutral): “uncontrolled despite optimized treatment with high-dose ICS–LABA or that requires such treatment to prevent it from becoming uncontrolled (12).”
- Epidemiology of Asthma in Children and Adults (2019, methodology): “However, when “severe asthma” was defined using ERS/ATS (35) or WHO (41) criteria, only a small number of children were classified as having severe asthma, suggesting that we need to look beyond the amount ofmedication and disease control when defining severe disease (46).”